SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?


To: Spekulatius who wrote (108)3/14/2001 6:48:11 AM
From: Mike McFarlandRead Replies (1) | Respond to of 1336
 
<did you just call the bottom>

I've done it before <g>

<Better to buy the cash rich SEPR, MLNM, ABGX,
INCY, VRTX, NBIX>
Can make and lose money anywhere, I'll hold what
little I have left in my pets and be a real bastard
of a shareholder--asking pointed questions at the
meetings, make them squirm, heh! Or I'll be there
cheering them on if they do well, either way, I've
had my fill of the market, and my cash stays out,
walking away rather than changing strategy.
Of course moving cash up another 25% isn't really
that dramatic for me, it isn't as if I bailed all
at once.

<high cash>
If I wanted a high cash angle in healthcare, I'd
probably end up in big pharma...that would really
put me out of phase, and I'd get whacked again.
Not that I have a bet on the table, but if I had
to bet, I'd guess that pharma is next to come down.
The carnage will spread even into the defensive
sectors. Or not. I'm not a fan of Fleck or anything,
and you wont see me subscribing to Grants, mainly
ambivalent.

And there is no point in setting stops, limiting
your losses if you're just going to be diving back
in the water again. The sharks can have the pool to
themselves.

No, higher priorities now which include my
insomnia and soothing a teething toddler.
Not in that order, heh, 4am now, sleepless
in Seattle of course...

Oh, The Seattle Times is doing a five part series
"Uninformed Consent", fairly interesting. David
Blech is in there, the Fred Hutch, CTI.
Worth a read.